Imagen de Portada

Oncolytic Virus Immunotherapy

Dear Readers, Oncolytic Viruses (OV) are self-propagating agents that can selectively induce the lysis of cancer cells while sparing normal tissues. OV-mediated cancer cell death is often immunogenic and triggers robust anticancer immune responses and immunoconversion of tumor microenvironments. Thi...

Descripción completa

Guardado en:
Formato: Online
Lenguaje:inglés
Publicado: MDPI - Multidisciplinary Digital Publishing Institute 2022
Materias:
oncolytic viruses
melanoma
immunotherapy
checkpoint inhibitors
combinatory therapy
reovirus
oncolytic virus
adenovirus
oncolytic
virotherapy
targeting
immunogenic cell death
αvβ6 integrin
oncolytic adenovirus
cancer immunotherapy
multi-stage
immunostimulatory
arming
HSV-1
clinical trials
newcastle disease virus
NDV
cancer
immune checkpoint inhibitor
PD-1
PD-L1
CTLA-4
type I interferon
herpes simplex virus
retargeted virus
tropism retargeting
tumor
checkpoint inhibitor
vaccination
antigen-agnostic vaccination
HER2
parvovirus
tumor microenvironment
combination therapy
glioblastoma
pancreatic cancer
colorectal cancer
measles virus
vector engineering
immune checkpoint blockade
antitumor immune response
delivery
genetic modification
biomarkers
personalized oncolyticvirotherapy
class I HLA
immunosurveillance
immunoediting
oncogenic signaling
RAS
DNA methyltransferase inhibitor (DNMTi)
viral mimicry
epigenetic silencing
adoptive T cell therapy
CAR T cell
pancreatic ductal adenocarcinoma
vesicular stomatitis virus
small molecule
cancer immune therapy
cancer therapy
n/a
thema EDItEUR::M Medicine and Nursing
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine
Acceso en línea:ONIX_20220506_9783036525495_238
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

ONIX_20220506_9783036525495_238

Ejemplares similares